학술논문

Fixed-Duration Pirtobrutinib Combined with Venetoclax Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia: Updated Results, Including MRD Data, from the BRUIN Phase 1b Study
Document Type
Journal
Source
BLOOD; NOV 2 2023, 142 5p. Supplement: 1
Subject
Language
English
ISSN
15280020